LUCILLE SULLIVAN: Open Payments
NPI 1346834033 · KEYPORT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,051 in 167 payments from 22 companies in 2025. Trend: 2023 $3,556 · 2024 $2,185 · 2025 $3,051
Food & beverage: $3,051
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 27 | $427 |
| Novo Nordisk Inc | 16 | $301 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 17 | $222 |
| Madrigal Pharmaceuticals | 9 | $183 |
| Radius Health, Inc. | 6 | $174 |
| Lilly USA, LLC | 13 | $170 |
| Ascensia Diabetes Care Us Inc. | 6 | $164 |
| Antares Pharma, Inc. | 11 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $146 |
| Esperion Therapeutics, Inc. | 6 | $146 |
Products named: TEPEZZA, JARDIANCE, REZDIFFRA, MOUNJARO, XYOSTED, Kerendia, NEXLETOL, TWIIST.
Industry payments across NJ — which companies pay providers there.
